Compared across 2 stores. Prices are checked against each store and labelled with when. Store links may earn us a commission.
This is a 1.0 oz (35 ml) Korean face cream built around 5% niacinamide and 5% tranexamic acid, plus 1% Melazero V2, aimed at fading dark spots, evening tone and tightening the look of pores. It is fragrance free and hypoallergenic, and the brand says it hydrates enough to replace a separate moisturizer with a non-sticky finish. Rivals usually sell niacinamide alone or pair it with vitamin C; this one stacks two brighteners with a pore-focused complex in a light cream.
In stockShips from abroad · duties may apply
Availability unknownSold by a.traders (96.7% positive, 224 ratings)Ships from Canada · duties may applyReturns: Set by the eBay seller; the eBay Money Back Guarantee covers an item that doesn't arrive or isn't as described.
Also available at
Store links may earn us a commission.
Lowest price we've seen: $8.91 on Nov 20 at eBay; highest $23.99 on Nov 6. Tracked across 22 stores since Nov 2.
With 4.8 out of 5 from about 14,000 ratings, buyers mostly report a light, non-greasy cream that absorbs fast and sits well under makeup. Many say tone looks more even and dark spots fade with regular use, and sensitive users like that it is fragrance free. A minority find it too small for the price or see slower results than expected.
Celimax Pore+Dark Spot Brightening Cream is a facial cream that targets pores, dark spots and uneven skin tone. It contains 5% niacinamide, 5% tranexamic acid and 1% Melazero V2. It also hydrates the skin, so no extra cream is needed.
The cream is light, non-greasy and non-sticky, and it absorbs quickly. It soothes sensitive or reactive skin to improve tone and texture. It is fragrance free and hypoallergenic, and it suits day and night use.
After cleansing, massage a pea-sized amount into the face, avoiding the eye area. Use it daily, morning and evening, before makeup.
It checks today's price at every store, compares the alternatives and answers in about a minute.



















